Topic: Multiple Sclerosis
(Reuters) - U.S. health regulators said on Tuesday they received a report of a multiple sclerosis patient who died within 24 hours of taking the first dose of Novartis AG's Gilenya.The U.S. Food and Drug Administration said at this time, it cannot ...
ZURICH (Reuters) - A third late-stage trial of Novartis' multiple sclerosis drug Gilenya did not throw up any new safety issues with the pill, going some way to alleviating concerns about possible risks linked to the potential blockbuster.The study results come just ...
PARIS (Reuters) - French drugmaker Sanofi said on Saturday that its experimental multiple sclerosis drug Lemtrada worked better than an older drug sold by competitor Merck KGaA at keeping patients free from relapses.New data from a late-stage trial showed that 78 percent ...
(Reuters) - Full data from a late-stage clinical trial of Biogen Idec Inc's experimental multiple sclerosis drug, BG-12, showed robust results across multiple measures and revealed no new safety concerns.The news sent the biotech company's shares soaring as much as 6.7 percent ...
(Reuters) - U.S. regulators have extended their review of Biogen Idec Inc's application to update the prescribing information for its multiple sclerosis drug Tysabri, the company said on Thursday.Biogen, which sells the drug with Irish drugmaker Elan Corp Plc, is seeking to ...
ZURICH (Reuters) - Swiss drugmaker Roche Holding said a mid-phase study found its ocrelizumab drug maintained significant reduction in disease activity for multiple sclerosis patients for almost two years, boosting its chances of success in late-stage trials."The study showed that the significant ...
The New York Times beat us at our own story.It is big news in Las Vegas when 2,000 to 3,000 residents who suffer from multiple sclerosis don't have a doctor or the ability to be treated in one of the largest metropolitan ...
Working night shifts as a teenager is not only exhausting; it also significantly increases the chance of developing multiple sclerosis later in life, a Swedish study published Tuesday showed."Our analysis revealed a significant association between working (night) shifts at a young age ...
NEW YORK (Reuters Health) - A new analysis of past studies concludes that there seems to be some link between multiple sclerosis and narrowed head and neck veins -- but more research is needed to be sure.The report, funded by Canadian Institutes ...
BOSTON (Reuters) - Over the past year, Biogen Idec Inc has given investors little to complain about. The biotechnology company, operating under new management, has restructured its operations, reported promising clinical trial data and seen its shares rise 72 percent.The question is: ...
Photo Gallery
-
MS sufferer Ann Brown re: case study for piece on the now-proven benefits of Vitamin D to sufferers.
MS sufferer Ann Brown (photographed at her home in Falkirk, Scotland), case ...ZUMA Press Inc - -
Purdy Challenges Assisted suicide ruling
Debbie Purdy arrives at the Royal Courts of Justice in London, Britain ...ZUMA Press Inc -
